Pérez-Sayáns M, Suárez-Peñaranda JM, Gayoso-Diz P, Barros-Angueira F, Gándara-Rey JM, García-García A. The role of p21^Waf1/CIP1 as a Cip/Kip type cell-cycle regulator in oral squamous cell carcinoma (Review)Med Oral Patol Oral Cir Bucal. 2013 Mar 1;18 (2):e219-25.

doi:10.4317/medoral.18213

http://dx.doi.org/doi:10.4317/medoral.18213

1. Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, Reboiras-Lopez MD, Gandara Rey JM, Garcia-Garcia A. Genetic and molecular alterations associated with oral squamous cell cancer (Review). Oncol Rep. 2009;22:1277-1282.
http://dx.doi.org/10.3892/or_00000565
PMid:19885577

2. Fillies T, Woltering M, Brandt B, Van Diest JP, Werkmeister R, Joos U, et al. Cell cycle regulating proteins p21 and p27 in prognosis of oral squamous cell carcinomas. Oncol Rep. 2007;17:355-359.
PMid:17203174

3. Kapranos N, Stathopoulos GP, Manolopoulos L, Kokka E, Papadimitriou C, Bibas A, et al. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value. Anticancer Res. 2001;21:521-528.
PMid:11299798

4. Brennan PA, Palacios-Callender M, Umar T, Tant S, Langdon JD. Expression of type 2 nitric oxide synthase and p21 in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2002;31:200-205.
http://dx.doi.org/10.1054/ijom.2001.0214
PMid:12102420

5. Queiroz AB, Focchi G, Dobo C, Gomes TS, Ribeiro DA, Oshima CT. Expression of p27, p21(WAF/Cip1), and p16(INK4a) in normal oral epithelium, oral squamous papilloma, and oral squamous cell carcinoma. Anticancer Res. 2010;30:2799-2803.
PMid:20683015

6. Horta MC, de Assis LA, de Souza AF, de Araujo VC, Gomez RS, Aguiar MC. p53 and p21WAF1/CIP1 overexpression at the invasive front of lower lip squamous cell carcinoma. J Oral Pathol Med. 2007;36:88-92.
http://dx.doi.org/10.1111/j.1600-0714.2007.00495.x
PMid:17238970

7. Nemes JA, Nemes Z, Marton IJ. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma. J Oral Pathol Med. 2005;34:274-279.
http://dx.doi.org/10.1111/j.1600-0714.2005.00310.x
PMid:15817070

8. Buajeeb W, Poomsawat S, Punyasingh J, Sanguansin S. Expression of p16 in oral cancer and premalignant lesions. J Oral Pathol Med. 2009;38:104-108.
http://dx.doi.org/10.1111/j.1600-0714.2008.00710.x
PMid:19192055

9. Vairaktaris E, Yapijakis C, Psyrri A, Spyridonidou S, Yannopoulos A, Lazaris A, et al. Loss of tumour suppressor p16 expression in initial stages of oral oncogenesis. Anticancer Res. 2007;27:979-984.
PMid:17465230

10. Suzuki H, Sugimura H, Hashimoto K. p16INK4A in oral squamous cell carcinomas--a correlation with biological behaviors: immunohistochemical and FISH analysis. J Oral Maxillofac Surg. 2006;64:1617-1623.
http://dx.doi.org/10.1016/j.joms.2005.11.097
PMid:17052587

11. van Oijen MG, Tilanus MG, Medema RH, Slootweg PJ. Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression. J Oral Pathol Med. 1998;27:367-375.
http://dx.doi.org/10.1111/j.1600-0714.1998.tb01969.x
PMid:9736425

12. Tatemoto Y, Osaki T, Yoneda K, Yamamoto T, Ueta E, Kimura T. Expression of p53 and p21 proteins in oral squamous cell carcinoma: correlation with lymph node metastasis and response to chemoradiotherapy. Pathol Res Pract. 1998;194:821-830.
http://dx.doi.org/10.1016/S0344-0338(98)80084-8

13. Yook JI, Kim J. Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas. Oral Oncol. 1998;34:198-203.
http://dx.doi.org/10.1016/S1368-8375(97)00091-2

14. Agarwal S, Mathur M, Shukla NK, Ralhan R. Expression of cyclin dependent kinase inhibitor p21waf1/cip1 in premalignant and malignant oral lesions: relationship with p53 status. Oral Oncol. 1998;34:353-360.
http://dx.doi.org/10.1016/S1368-8375(98)00021-9

15. Warnakulasuriya KA, Tavassoli M, Johnson NW. Relationship of p53 overexpression to other cell cycle regulatory proteins in oral squamous cell carcinoma. J Oral Pathol Med. 1998;27:376-381.
http://dx.doi.org/10.1111/j.1600-0714.1998.tb01970.x
PMid:9736426

16. Schoelch ML, Regezi JA, Dekker NP, Ng IO, McMillan A, Ziober BL, et al. Cell cycle proteins and the development of oral squamous cell carcinoma. Oral Oncol. 1999;35:333-342.
http://dx.doi.org/10.1016/S1368-8375(98)00098-0

17. Ng IO, Lam KY, Ng M, Regezi JA. Expression of p21/waf1 in oral squamous cell carcinomas--correlation with p53 and mdm2 and cellular proliferation index. Oral Oncol. 1999;35:63-69.
http://dx.doi.org/10.1016/S1368-8375(98)00083-9

18. Kudo Y, Takata T, Ogawa I, Sato S, Nikai H. Expression of p53 and p21CIP1/WAF1 proteins in oral epithelial dysplasias and squamous cell carcinomas. Oncol Rep. 1999;6:539-545.
PMid:10203588

19. Ralhan R, Agarwal S, Mathur M, Wasylyk B, Srivastava A. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer. Clin Cancer Res. 2000;6:2440-2447.
PMid:10873097

20. Xie X, Clausen OP, Boysen M. Prognostic significance of p21WAF1/CIP1 expression in tongue squamous cell carcinomas. Arch Otolaryngol Head Neck Surg. 2002;128:897-902.
PMid:12162767

21. Yen-Ping Kuo M, Huang JS, Kok SH, Kuo YS, Chiang CP. Prognostic role of p21WAF1 expression in areca quid chewing and smoking-associated oral squamous cell carcinoma in Taiwan. J Oral Pathol Med. 2002;31:16-22.
http://dx.doi.org/10.1046/j.0904-2512.2001.10055.x
PMid:11896818

22. Pande P, Soni S, Kaur J, Agarwal S, Mathur M, Shukla NK, et al. Prognostic factors in betel and tobacco related oral cancer. Oral Oncol. 2002;38:491-499.
http://dx.doi.org/10.1016/S1368-8375(01)00090-2

23. Kuropkat C, Venkatesan TK, Caldarelli DD, Panje WR, Hutchinson J, Preisler HD, et al. Abnormalities of molecular regulators of proliferation and apoptosis in carcinoma of the oral cavity and oropharynx. Auris Nasus Larynx. 2002;29:165-174.
http://dx.doi.org/10.1016/S0385-8146(01)00129-8

24. Choi HR, Tucker SA, Huang Z, Gillenwater AM, Luna MA, Batsakis JG, et al. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis. Int J Oncol. 2003;22:409-414.
PMid:12527941

25. Gonzalez-Moles MA, Ruiz-Avila I, Martinez JA, Gil-Montoya JA, Esteban F, Gonzalez-Moles S, et al. P21WAF1/CIP1 protein and tongue cancer prognosis. Anticancer Res. 2004;24:3225-3231.
PMid:15510615

26. Neves Ada C, Mesquita RA, Novelli MD, Toddai E, De Sousa SO. Comparison between immunohistochemical expression of cyclin D1 and p21 and histological malignancy graduation of oral squamous cell carcinomas. Braz Dent J. 2004;15:93-98.
PMid:15776189

27. Ahmed MM. Expression profile of apoptotic mediators and proliferative markers in oral squamous cell carcinoma. J Egypt Natl Canc Inst. 2009;21:85-92.
PMid:21057559

28. Queiroz AB, Focchi G, Dobo C, Gomes TS, Ribeiro DA, Oshima CT. Expression of p27, p21(WAF/Cip1), and p16(INK4a) in normal oral epithelium, oral squamous papilloma, and oral squamous cell carcinoma. Anticancer Res. 2010;30:2799-2803.
PMid:20683015

29. Cardinali M, Jakus J, Shah S, Ensley JF, Robbins KC, Yeudall WA. p21(WAF1/Cip1) retards the growth of human squamous cell carcinomas in vivo. Oral Oncol. 1998;34:211-218.
http://dx.doi.org/10.1016/S1368-8375(97)00083-3

30. Osaki T, Kimura T, Tatemoto Y, Dapeng L, Yoneda K, Yamamoto T. Diffuse mode of tumor cell invasion and expression of mutant p53 protein but not of p21 protein are correlated with treatment failure in oral carcinomas and their metastatic foci. Oncology. 2000;59:36-43.
http://dx.doi.org/10.1159/000012135
PMid:10895065

31. Yanamoto S, Kawasaki G, Yoshitomi I, Mizuno A. p53, mdm2, and p21 expression in oral squamous cell carcinomas: relationship with clinicopathologic factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:593-600.
http://dx.doi.org/10.1067/moe.2002.127404
PMid:12424454

32. Chang KW, Lin SC, Kwan PC, Wong YK. Association of aberrant p53 and p21(WAF1) immunoreactivity with the outcome of oral verrucous leukoplakia in Taiwan. J Oral Pathol Med. 2000;29:56-62.
http://dx.doi.org/10.1034/j.1600-0714.2000.290202.x
PMid:10718400

33. Hogmo A, Lindskog S, Lindholm J, Kuylenstierna R, Auer G, Munck-Wikland E. Preneoplastic oral lesions: the clinical value of image cytometry DNA analysis, p53 and p21/WAF1 expression. Anticancer Res. 1998;18:3645-3650.
PMid:9854471

34. Soares RC, Oliveira MC, de Souza LB, Costa Ade L, Pinto LP. Detection of HPV DNA and immunohistochemical expression of cell cycle proteins in oral carcinoma in a population of Brazilian patients. J Appl Oral Sci. 2008;16:340-344.
http://dx.doi.org/10.1590/S1678-77572008000500007
PMid:19089231

35. Gomes CC, Drummond SN, Guimaraes AL, Andrade CI, Mesquita RA, Gomez RS. P21/ WAF1 and cyclin D1 variants and oral squamous cell carcinoma. J Oral Pathol Med. 2008;37:151-156.
http://dx.doi.org/10.1111/j.1600-0714.2007.00604.x
PMid:18251939

36. Ibrahim SO, Lillehaug JR, Dolphine O, Johnson NW, Warnakulasuriya KA, Vasstrand EN. Mutations of the cell cycle arrest gene p21WAF1, but not the metastasis-inducing gene S100A4, are frequent in oral squamous cell carcinomas from Sudanese toombak dippers and non-snuff-dippers from the Sudan, Scandinavia, USA and UK. Anticancer Res. 2002;22:1445-1451.
PMid:12168821

37. Yoneda K, Yamamoto T, Ueta E, Osaki T. Induction of cyclin-dependent kinase inhibitor p21 in vesnarinone-induced differentiation of squamous cell carcinoma cells. Cancer Lett. 1998;133:35-45.
http://dx.doi.org/10.1016/S0304-3835(98)00187-6

38. Yoneda K, Yamamoto T, Osaki T. p53- and p21-independent apoptosis of squamous cell carcinoma cells induced by 5-fluorouracil and radiation. Oral Oncol. 1998;34:529-537.
http://dx.doi.org/10.1016/S1368-8375(98)00036-0

39. Aguero MF, Facchinetti MM, Sheleg Z, Senderowicz AM. Phenoxodiol, a novel isoflavone, induces G1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1/CIP1. Cancer Res. 2005;65:3364-3373.
PMid:15833870

40. Black JD. Protein kinase C-mediated regulation of the cell cycle. Front Biosci. 2000;5:D406-23.
http://dx.doi.org/10.2741/Black
PMid:10762593